Portola Pharmaceuticals, Inc.
Portola Pharmaceuticals, Inc.
270 E. Grand Avenue
South San Francisco, CA 94080
(650) 246 7000
Latest News
- FDA Approves Bevyxxa (betrixaban) for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients - June 23, 2017
- Portola Pharmaceuticals Announces FDA Accepts NDA for Priority Review for Oral, Factor Xa Inhibitor Anticoagulant Betrixaban - December 23, 2016
- Portola Pharmaceuticals Submits NDA to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism in Acute Medically Ill Patients - October 25, 2016
Drugs Associated with Portola Pharmaceuticals, Inc.
Portola Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 1 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Andexxa
Generic name: coagulation factor Xa Drug class: anticoagulant reversal agents |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Bevyxxa
Generic name: betrixaban Drug class: factor Xa inhibitors |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||